Asterias Biotherapeutics Inc Class A (AST)

0.94
AMEX
Prev Close 0.94
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.51 / 1.65
Exchange AMEX
Div & Yield N.A. (N.A)

Latest News

Notable Tuesday Option Activity: AST, URI, X

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Asterias Biotherapeutics Inc , where a total of 852 contracts have traded so far, representing approximately 85,200 underlying shares. That amounts to about 41.9% of AST's average daily trading volume over the past month of 203,430 shares.

Asterias Receives Regulatory Clearance To Initiate Clinical Study Of AST-VAC2 In Subjects With Early And Late Stage Non-Small Cell Lung Cancer

Asterias Receives Regulatory Clearance To Initiate Clinical Study Of AST-VAC2 In Subjects With Early And Late Stage Non-Small Cell Lung Cancer

Industry News Supports Development of First-in-Class Allogeneic Cancer Immunotherapy

Asterias Announces Major AST-VAC2 Development Milestone: First CGMP-Compliant Lot Successfully Manufactured To Support First Clinical Study Of AST-VAC2

Asterias Announces Major AST-VAC2 Development Milestone: First CGMP-Compliant Lot Successfully Manufactured To Support First Clinical Study Of AST-VAC2

Successful Production Run Provides Sufficient AST-VAC2 Supply to Initiate Clinical Study in Non-Small Cell Lung Cancer Expected to Begin in Second Half of 2017

Asterias Enrolls First Patient In Final Cohort Of SCiStar Clinical Trial

Asterias Enrolls First Patient In Final Cohort Of SCiStar Clinical Trial

Enrollment for entire SCiStar study expected to be completed by end-2017

Asterias Biotherapeutics Opens Two Additional Clinical Sites For AST-OPC1 SCiStar Study

Asterias Biotherapeutics Opens Two Additional Clinical Sites For AST-OPC1 SCiStar Study

New sites include Thomas Jefferson University Hospital and UC San Diego Health

Noteworthy Wednesday Option Activity: AST, KITE, TDOC

Noteworthy Wednesday Option Activity: AST, KITE, TDOC

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Asterias Biotherapeutics Inc , where a total volume of 767 contracts has been traded thus far today, a contract volume which is representative of approximately 76,700 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 47.8% of AST's average daily trading volume over the past month, of 160,485 shares.

BioTime, Inc. Reports Second Quarter Results And Recent Corporate Accomplishments

BioTime, Inc. Reports Second Quarter Results And Recent Corporate Accomplishments

BioTime, Inc. (NYSE MKT:BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today reported financial results for the second quarter ended June 30, 2016 and provided a...

ASTERIAS BIOTHERAPEUTICS (AST) SHAREHOLDER ALERT - Andrews & Springer LLC Is Investigating Asterias Biotherapeutics, Inc. For Potential Breach Of Fiduciary Duty

ASTERIAS BIOTHERAPEUTICS (AST) SHAREHOLDER ALERT - Andrews & Springer LLC Is Investigating Asterias Biotherapeutics, Inc. For Potential Breach Of Fiduciary Duty

Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against Asterias...